Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2024 Mar 1.

Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2023 Feb 28;16(3):e009494. doi: 10.1161/CIRCOUTCOMES.122.009494

Figure 3. — Survival curves of patients receiving anticoagulants (Blue) or not receiving anticoagulants (Red) within 30 days of discharge from hospitalization with sepsis and new-onset atrial fibrillation.

Figure 3a. Incidence of stroke and transient ischemic attack for patients receiving anticoagulants or not receiving anticoagulants within 30 days of discharge from hospitalization with sepsis and new-onset atrial fibrillation, estimated from marginal structural models with Super Learner-generated propensity scores and per protocol analysis.

Figure 3b. Incidence of major bleeding for patients receiving anticoagulants or not receiving anticoagulants within 30 days of discharge from hospitalization with sepsis and new-onset atrial fibrillation, estimated from marginal structural models with Super Learner-generated propensity scores and per protocol analysis.

Figure 3. — Survival curves of patients receiving anticoagulants (Blue) or not receiving anticoagulants (Red) within 30 days of discharge from hospitalization with sepsis and new-onset atrial fibrillation.

Figure 3a. Incidence of stroke and transient ischemic attack for patients receiving anticoagulants or not receiving anticoagulants within 30 days of discharge from hospitalization with sepsis and new-onset atrial fibrillation, estimated from marginal structural models with Super Learner-generated propensity scores and per protocol analysis.

Figure 3b. Incidence of major bleeding for patients receiving anticoagulants or not receiving anticoagulants within 30 days of discharge from hospitalization with sepsis and new-onset atrial fibrillation, estimated from marginal structural models with Super Learner-generated propensity scores and per protocol analysis.